Healio
Healio

Sitemap

December 11, 2010 Articles

Filter by Available Specialty

Filter by specialty

  1. Fulvestrant 500 mg shows promise for HR+ breast cancer treatment
  2. Lapatinib, trastuzumab may be effective as combination therapy in HER+ breast cancer
  3. Response rates higher with trastuzumab vs. lapatinib as adjuvant therapy for HER2+ metastatic breast cancer